Zobrazeno 1 - 10
of 48
pro vyhledávání: '"Sindhu Ramchandren"'
Autor:
Binyamin Eisen, Ronen Ben Jehuda, Ashley J. Cuttitta, Lucy N. Mekies, Irina Reiter, Sindhu Ramchandren, Michael Arad, Daniel E. Michele, Ofer Binah
Publikováno v:
Stem Cell Research, Vol 29, Iss , Pp 111-114 (2018)
Duchenne muscular dystrophy (DMD) is an X-linked progressive muscle degenerative disease caused by mutations in the dystrophin gene. We generated induced pluripotent stem cells (iPSCs) from a 13-year-old male patient carrying a deletion mutation of e
Externí odkaz:
https://doaj.org/article/d79c103b1f9f407b90f27d64178fe354
Autor:
Vera, Fridman, Stefan, Sillau, Jacob, Bockhorst, Kaitlin, Smith, Isabella, Moroni, Emanuela, Pagliano, Chiara, Pisciotta, Guiseppe, Piscosquito, Matilde, Laurá, Francesco, Muntoni, Chelsea, Bacon, Shawna, Feely, Tiffany, Grider, Laurie, Gutmann, Rosemary, Shy, Janel, Wilcox, David N, Herrmann, Jun, Li, Sindhu, Ramchandren, Charlotte J, Sumner, Thomas E, Lloyd, John, Day, Carly E, Siskind, Sabrina W, Yum, Reza, Sadjadi, Richard S, Finkel, Steven S, Scherer, Davide, Pareyson, Mary M, Reilly, Michael E, Shy
Publikováno v:
Annals of Neurology. 93:563-576
The paucity of longitudinal natural history studies in MPZ neuropathy remains a barrier to clinical trials. We have completed a longitudinal natural history study in patients with MPZ neuropathies across 13 sites of the Inherited Neuropathies Consort
Autor:
Juan-José Pérez-Ruixo, Yaowei Zhu, Martine Neyens, Marie-Helene Jouvin, Sindhu Ramchandren, Yan Xu, Jocelyn Leu, Anne-Gaëlle Dosne, Yuan Xiong, Belén Valenzuela, Leona Ling, Partha Nandy, Hong Sun
Publikováno v:
Sunday, April 23.
Autor:
Catherine Najem, Jagriti Craig, Lisa Christopher-Stine, Federico Zazzetti, Wim Noel, Sindhu Ramchandren, Christopher Blango, Chetan S. Karyekar, Rohit Aggarwal
Publikováno v:
Wednesday, April 26.
Autor:
Tyler Rehbein, Tong Tong Wu, Simona Treidler, Davide Pareyson, Richard Lewis, Sabrina W Yum, Brett A McCray, Sindhu Ramchandren, Joshua Burns, Jun Li, Richard S Finkel, Steven S Scherer, Stephan Zuchner, Michael E Shy, Mary M Reilly, David N Herrmann
Publikováno v:
Brain.
Recessive SH3TC2 variants cause Charcot-Marie-Tooth disease type 4C (CMT4C). CMT4C is typically a sensorimotor demyelinating polyneuropathy, marked by early onset spinal deformities, but its clinical characteristics and severity are quite variable. C
Autor:
Isabella Moroni, Federica Rachele Danti, Davide Pareyson, Emanuela Pagliano, Giuseppe Piscosquito, Maria Foscan, Alessia Marchi, Anna Ardissone, Silvia Genitrini, Tong Tong Wu, Michael E Shy, Sindhu Ramchandren
Publikováno v:
Journal of the Peripheral Nervous System. 27:127-130
Validation of the parent‐proxy pediatric Charcot‐Marie‐Tooth disease quality of life outcome measure
Autor:
Sindhu Ramchandren, John Day
Publikováno v:
Journal of the Peripheral Nervous System.
Publikováno v:
Neurology. 99:S41.1-S41
ObjectiveWe describe an open-label study of nipocalimab to determine the effect of nipocalimab in pediatric participants with gMG.BackgroundNipocalimab is a high affinity, fully human, aglycosylated, effectorless IgG1 anti FcRn monoclonal antibody th
Publikováno v:
Neurology. 99:S41.2-S41
ObjectiveWe describe Vivacity-MG3. our pivotal Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Nipocalimab Administered to Adults With gMG
Autor:
Sindhu Ramchandren, Jeff Guptill, Carlo Antozzi, Vera Bril, Josep Gamez, Sven Meuth, Richard Nowak, Dianna Quan, Maria Teresa Sevilla Mantecon, Leona Ling, Yaowei Zhu, Keith Karcher, Hong Sun
Publikováno v:
MUSCLE & NERVE
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
ObjectiveTo evaluate the relationship between clinical improvement in Myasthenia Gravis-Activities of Daily Living (MG-ADL) scores and the pharmacodynamic effects of IgG autoantibody lowering induced by nipocalimab in the Vivacity MG Phase 2 study.Ba
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce5398d2652ee9698fdb4db2c0f1218d
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=16877
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=16877